Navigation Links
Avoiding a cartography catastrophe

KNOXVILLE, TN Since the mid-nineteenth century, maps have helped elucidate the deadly mysteries of diseases like cholera and yellow fever. Yet today's global mapping of infectious diseases is considerably unreliable and may do little to inform the control of potential outbreaks, according to a new systematic mapping review of all clinically important infectious diseases known to humans.

Of the 355 infectious diseases assessed in the review, 174 showed a strong rationale for mapping and less than 5 percent of those have been mapped reliably. Unreliable mapping makes it difficult to fully understand the geographic scope and threat of disease and therefore make informed policy recommendations for managing it, write the authors of the study, which appears as open access on Feb. 4 in the journal Philosophical Transactions of the Royal Society B.

An online, open-access database, which accompanies the study, provides a quantitative scheme for evaluating the quality of data available for each infectious disease as well as specific mapping recommendations for each disease. Among the recommendations for improving disease cartography are the use of new crowdsourcing techniques to gather data, such as analyzing the content and frequency of Twitter messages about disease. Twitter feeds during the 2009 H1N1 flu outbreak, for example, predicted outbreaks sooner than traditional disease surveillance methods.

"We have shown that novel solutions exist to enable us to use up-to-date data and technology to rapidly improve our geographic knowledge of a wide range of clinically important pathogens," said Katherine Battle, one of the study's co-authors from the University of Oxford.

Unique to the review is the inclusion of how the basic reproduction rate, which is the primary epidemiological number used to determine the degree which a disease can spread through a population, might vary among pathogens.

"There is a clear need for better estimates of the potential growth of infectious diseases that allow spatial variations to be taken into consideration, and this paper is a wonderful contribution to help us meet this need," said Louis Gross, the director of the National Institute for Mathematical and Biological Synthesis, which sponsored a workshop in 2011 that produced the paper.


Contact: Catherine Crawley
National Institute for Mathematical and Biological Synthesis (NIMBioS)

Post Your Comments:
Related Image:
Avoiding a cartography catastrophe
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: ... area for financial services, but it also plays a fundamental ...
Breaking Biology News(10 mins):
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
Breaking Biology Technology: